Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07671872 · ClinicalTrials.gov registry record · NA
Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease
A NA study, sponsored by University of Miami.
- Not yet
- Registry status
- NA
- Development phase
- 122
- Enrollment target
NCT07671872: Clinical Trial NA study, sponsored by University of Miami.
NCT07671872 is a NA study that has not yet begun recruiting, run by University of Miami. The registered enrollment target is 122 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07671872, a NA study, has not yet begun recruiting, sponsored by University of Miami.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 122 participants
- Enrollment target
Study Summary
The purpose of this study is to test the effect of an anti-inflammatory diet tailored for patients living in the United States with Crohn's Disease (CD) on clinical symptoms and disease inflammation and to identify biomarkers of response to dietary therapy.
Primary Outcome
Clinical response is defined as a ≥70-point reduction from baseline in the Crohn's Disease Activity Index (CDAI). The outcome is the percentage of participants who achieve this response following the dietary intervention.
Interventions
- BEHAVIORAL Catered Anti-Inflammatory Diet
- BEHAVIORAL Diet Guidance for Usual Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2026-08 |
| Est. Completion | 2030-08 |
| Phase | NA |
What is known before NCT07671872 opens enrollment
NCT07671872 is an interventional study that assigns participants to a tested intervention. The registered 122 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Catered Anti-Inflammatory Diet is the first listed.
NCT07671872 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07671872 about?
NCT07671872 is a clinical study titled "Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease". The purpose of this study is to test the effect of an anti-inflammatory diet tailored for patients living in the United States with Crohn's Disease (CD) on clinical symptoms and disease inflammation and to identify biomarkers of response to dietary therapy.
What is the current status of trial NCT07671872?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 122 participants. The study started on 2026-08. Estimated completion is 2030-08.
What interventions are being tested in trial NCT07671872?
The interventions under investigation include: Catered Anti-Inflammatory Diet (BEHAVIORAL), Diet Guidance for Usual Diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT07671872?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07671872's enrollment target sits among peer trials
122 762nd of 2000 higher than 1,239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03363373 · 122 participants · Phase 2
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow
- NCT03463954 · 122 participants · NA
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
- NCT04503265 · 122 participants · Phase 1
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
- NCT04700527 · 122 participants · Phase 1
The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia